Funding Research to Cure Arthritis
Grant Opportunity: $100,000 annual research grants for newer MD and PhD investigators at US institutions
• One- and two-year grants
• 12-15 grants awarded per year
• $1.3 million research awards in 2017-18
• 4-Star Charity Navigator Rating 9 consecutive years
Avanos Medical is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.
Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. The company has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical to make it a global leader in active orthopaedic healing. For more information, visit www.BioventusGlobal.com.
Boston Imaging Core Lab (BICL) is dedicated to enhancing the synergy between clinical excellence and cutting edge scientific research with a team of expert and highly specialized radiologists. BICL radiologists are among the leaders in musculoskeletal imaging with a strong focus on the application of MRI in osteoarthritis research. Our team of expert radiologists are involved in the latest innovative scientific activities across the globe. We believe that the most important component of our services lies in the expertise each member of our team brings to the company for our clients.
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives.
Mylan is a global healthcare company focused on making high quality medicines available to everyone who needs them. Our heritage of being a provider of generic pharmaceuticals goes back to our founding in West Virginia in 1961. Today, we are passionate champions for better health around the world with a platform unmatched in the industry.
Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation, we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.